Many of those who’ve suffered from illness or disease would have received the advice to “stay positive”. Is this sage advice that can truly have a positive effect on health, or an added burden for someone who is already suffering – the need to also feel good about it?
We asked five experts in various fields whether a positive mindset can affect outcomes for those suffering from illness and disease.
Five out of five experts said yes

However, they had some important caveats. It depends on the disease – for example, one expert said studies in cancer have not found positive thinking affects disease progression or the likelihood of early death.
And while our mental health can have powerful effects on our physical health, the perceived need to “stay positive” can be an added burden during a difficult time. So it’s also important to remember grief is normal.
Here are the experts’ detailed responses:
If you have a “yes or no” health question you’d like posed to Five Experts, email your suggestion to: [email protected]



Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
EUR/USD Smashes 1.1660 as ADP Jobs Massacre Crushes the Dollar
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition 



